FHLC vs. PBPH
FHLC (Fidelity MSCI Health Care Index ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - FHLC tracks the MSCI USA IMI Health Care Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. Their correlation of 0.87 suggests significant overlap in exposure. FHLC charges 0.08%/yr vs 0.13%/yr for PBPH.
Performance
FHLC vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FHLC achieves a -3.90% return, which is significantly lower than PBPH's -1.13% return.
FHLC
- 1D
- 0.82%
- 1M
- 1.50%
- YTD
- -3.90%
- 6M
- -4.11%
- 1Y
- 14.43%
- 3Y*
- 6.14%
- 5Y*
- 4.50%
- 10Y*
- 9.14%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
FHLC vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | -3.90% | -2.27% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between FHLC and PBPH is 0.87, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.87 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FHLC vs. PBPH — Risk / Return Rank
FHLC
PBPH
FHLC vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FHLC | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.18 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.40 | — | — |
| Martin ratioReturn relative to average drawdown | 3.52 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FHLC | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.01 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.30 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.61 | -0.04 | +0.65 |
Drawdowns
FHLC vs. PBPH - Drawdown Comparison
The maximum FHLC drawdown since its inception was -28.76%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for FHLC and PBPH.
Loading charts...
Drawdown Indicators
| FHLC | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.76% | -11.10% | -17.66% |
Max Drawdown (1Y)Largest decline over 1 year | -10.38% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -16.87% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -17.73% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -28.76% | — | — |
Current DrawdownCurrent decline from peak | -6.96% | -8.69% | +1.73% |
Average DrawdownAverage peak-to-trough decline | -5.19% | -4.23% | -0.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.11% | — | — |
Volatility
FHLC vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| FHLC | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.05% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 10.11% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 14.33% | 16.78% | -2.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.97% | 16.78% | -1.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.81% | 16.78% | +0.03% |
FHLC vs. PBPH - Expense Ratio Comparison
FHLC has a 0.08% expense ratio, which is lower than PBPH's 0.13% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
FHLC vs. PBPH - Dividend Comparison
FHLC's dividend yield for the trailing twelve months is around 1.43%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | 1.43% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
FHLC and PBPH have a correlation of 0.87, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, FHLC is cheaper at 0.08% per year. The better choice depends on whether you care most about return, fees, risk, or income.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.13% for PBPH.
FHLC has the higher dividend yield at 1.43%, compared with 0.09% for PBPH.
FHLC tracks MSCI USA IMI Health Care Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Fidelity and Portfolio Building Block. Their fees differ too: 0.08% for FHLC and 0.13% for PBPH.
Find the right allocation for FHLC and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer